Mindray Expands Its Cardiac Biomarker Portfolio with Cutting-Edge hs-cTnI and NT-proBNP Assays, Empowering Enhanced Cardiovascular Diseases Care ...Middle East

SHENZHEN, China, Oct. 23, 2023 /PRNewswire/ -- Mindray (SZSE: 300760), a global leader in medical devices and solutions, introduces high-sensitivity troponin I (hs-cTnI) and NT-proBNP cardiac biomarkers. The additions have enhanced Mindray's diverse portfolio of cardiac biomarkers for...

Hence then, the article about mindray expands its cardiac biomarker portfolio with cutting edge hs ctni and nt probnp assays empowering enhanced cardiovascular diseases care was published today ( Monday 23/10/2023 - 01:24 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Mindray Expands Its Cardiac Biomarker Portfolio with Cutting-Edge hs-cTnI and NT-proBNP Assays, Empowering Enhanced Cardiovascular Diseases Care )

Also on site :

• Sony’s Indian Version of ‘Who Wants to Be a Millionaire?’ Hosted by Amitabh Bachchan, Adds Google Gemini as AI Guide (EXCLUSIVE)
• ‘Naruto’ Movie Launches Global Casting Search to Find Actors to Play Live-Action Naruto, Sasuke and Sakura
• Anthropologie's 'Very Cute' Bow Stoneware Platter 'Adds a Romantic Touch to the Tablescape' for Just $32